Fresenius Medical Care AG & Co. KGaA (FME) Given a €88.00 Price Target by Goldman Sachs Group Analysts

Goldman Sachs Group set a €88.00 ($102.33) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research note published on Friday. The firm currently has a buy rating on the stock.

Other equities research analysts also recently issued research reports about the stock. Sanford C. Bernstein set a €107.00 ($124.42) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research note on Thursday, July 12th. Berenberg Bank set a €100.80 ($117.21) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research note on Thursday, July 12th. Bank of America set a €102.00 ($118.60) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research note on Tuesday, July 10th. Nord/LB set a €102.00 ($118.60) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research note on Friday, July 6th. Finally, Deutsche Bank set a €105.00 ($122.09) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research note on Monday, July 16th. Eight research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. The company presently has a consensus rating of Buy and an average target price of €92.13 ($107.13).

Shares of Fresenius Medical Care AG & Co. KGaA stock opened at €70.50 ($81.98) on Friday. Fresenius Medical Care AG & Co. KGaA has a 1 year low of €75.53 ($87.83) and a 1 year high of €93.82 ($109.09).



Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

Recommended Story: Moving Average (MA)

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply